BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alonso-Alconada D, Alvarez A, Arteaga O, Martínez-Ibargüen A, Hilario E. Neuroprotective effect of melatonin: a novel therapy against perinatal hypoxia-ischemia. Int J Mol Sci 2013;14:9379-95. [PMID: 23629670 DOI: 10.3390/ijms14059379] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Uyanıkgil Y, Turgut M, Baka M. Effects of Melatonin on the Cerebellum of Infant Rat Following Kaolin-Induced Hydrocephalus: a Histochemical and Immunohistochemical Study. Cerebellum 2017;16:142-50. [PMID: 27113349 DOI: 10.1007/s12311-016-0778-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
2 Wang S, Shi X, Laborda P. Indole-based melatonin analogues: Synthetic approaches and biological activity. European Journal of Medicinal Chemistry 2020;185:111847. [DOI: 10.1016/j.ejmech.2019.111847] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 14.0] [Reference Citation Analysis]
3 Cánovas-Ahedo M, Alonso-Alconada D. [Combined therapy in neonatal hypoxic-ischaemic encephalopathy]. An Pediatr (Engl Ed) 2019;91:59.e1-7. [PMID: 31109785 DOI: 10.1016/j.anpedi.2019.04.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 D'Angelo G, Chimenz R, Reiter RJ, Gitto E. Use of Melatonin in Oxidative Stress Related Neonatal Diseases. Antioxidants (Basel). 2020;9. [PMID: 32498356 DOI: 10.3390/antiox9060477] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
5 Hasan M, Genovese S, Fiorito S, Epifano F, Witt-enderby PA. Oxyprenylated Phenylpropanoids Bind to MT1 Melatonin Receptors and Inhibit Breast Cancer Cell Proliferation and Migration. J Nat Prod 2017;80:3324-9. [DOI: 10.1021/acs.jnatprod.7b00853] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
6 Luo C, Yang Q, Liu Y, Zhou S, Jiang J, Reiter RJ, Bhattacharya P, Cui Y, Yang H, Ma H, Yao J, Lawler SE, Zhang X, Fu J, Rozental R, Aly H, Johnson MD, Chiocca EA, Wang X. The multiple protective roles and molecular mechanisms of melatonin and its precursor N-acetylserotonin in targeting brain injury and liver damage and in maintaining bone health. Free Radic Biol Med 2019;130:215-33. [PMID: 30315933 DOI: 10.1016/j.freeradbiomed.2018.10.402] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 10.0] [Reference Citation Analysis]
7 Yang Y, Jiang S, Dong Y, Fan C, Zhao L, Yang X, Li J, Di S, Yue L, Liang G, Reiter RJ, Qu Y. Melatonin prevents cell death and mitochondrial dysfunction via a SIRT1-dependent mechanism during ischemic-stroke in mice. J Pineal Res 2015;58:61-70. [DOI: 10.1111/jpi.12193] [Cited by in Crossref: 150] [Cited by in F6Publishing: 150] [Article Influence: 21.4] [Reference Citation Analysis]
8 Schuch CP, Jeffers MS, Antonescu S, Nguemeni C, Gomez-Smith M, Pereira LO, Morshead CM, Corbett D. Enriched rehabilitation promotes motor recovery in rats exposed to neonatal hypoxia-ischemia. Behav Brain Res 2016;304:42-50. [PMID: 26876139 DOI: 10.1016/j.bbr.2016.02.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
9 Wesselhoeft R, Rasmussen L, Jensen PB, Jennum PJ, Skurtveit S, Hartz I, Reutfors J, Damkier P, Bliddal M, Pottegård A. Use of hypnotic drugs among children, adolescents, and young adults in Scandinavia. Acta Psychiatr Scand 2021;144:100-12. [PMID: 34021908 DOI: 10.1111/acps.13329] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Aly H, Elmahdy H, El-Dib M, Rowisha M, Awny M, El-Gohary T, Elbatch M, Hamisa M, El-Mashad AR. Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study. J Perinatol 2015;35:186-91. [PMID: 25393080 DOI: 10.1038/jp.2014.186] [Cited by in Crossref: 122] [Cited by in F6Publishing: 109] [Article Influence: 17.4] [Reference Citation Analysis]
11 Inder TE, Volpe JJ. Hypoxic-Ischemic Injury in the Term Infant. Volpe's Neurology of the Newborn. Elsevier; 2018. pp. 510-563.e15. [DOI: 10.1016/b978-0-323-42876-7.00020-x] [Cited by in Crossref: 8] [Article Influence: 2.7] [Reference Citation Analysis]
12 Hu Y, Wang Z, Pan S, Zhang H, Fang M, Jiang H, Zhang H, Gao Z, Xu K, Li Z, Xiao J, Lin Z. Melatonin protects against blood-brain barrier damage by inhibiting the TLR4/ NF-κB signaling pathway after LPS treatment in neonatal rats. Oncotarget 2017;8:31638-54. [PMID: 28404943 DOI: 10.18632/oncotarget.15780] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 10.3] [Reference Citation Analysis]
13 Pastor JC, Rojas J, Pastor-Idoate S, Di Lauro S, Gonzalez-Buendia L, Delgado-Tirado S. Proliferative vitreoretinopathy: A new concept of disease pathogenesis and practical consequences. Prog Retin Eye Res 2016;51:125-55. [PMID: 26209346 DOI: 10.1016/j.preteyeres.2015.07.005] [Cited by in Crossref: 123] [Cited by in F6Publishing: 117] [Article Influence: 20.5] [Reference Citation Analysis]
14 Pisani F, Fusco C, Nagarajan L, Spagnoli C. Acute symptomatic neonatal seizures, brain injury, and long-term outcome: The role of neuroprotective strategies. Expert Rev Neurother 2021;21:189-203. [PMID: 33176104 DOI: 10.1080/14737175.2021.1848547] [Reference Citation Analysis]
15 Klimentova J, Cebova M, Barta A, Matuskova Z, Vrankova S, Rehakova R, Kovacsova M, Pechanova O. Effect of melatonin on blood pressure and nitric oxide generation in rats with metabolic syndrome. Physiol Res 2016;65:S373-80. [PMID: 27775422 DOI: 10.33549/physiolres.933436] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
16 Albrecht M, Zitta K, Groenendaal F, van Bel F, Peeters-Scholte C. Neuroprotective strategies following perinatal hypoxia-ischemia: Taking aim at NOS. Free Radic Biol Med 2019;142:123-31. [PMID: 30818057 DOI: 10.1016/j.freeradbiomed.2019.02.025] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
17 Revuelta M, Arteaga O, Montalvo H, Alvarez A, Hilario E, Martinez-Ibargüen A. Antioxidant Treatments Recover the Alteration of Auditory-Evoked Potentials and Reduce Morphological Damage in the Inferior Colliculus after Perinatal Asphyxia in Rat. Brain Pathol 2016;26:186-98. [PMID: 25990815 DOI: 10.1111/bpa.12272] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
18 Taniguti EH, Ferreira YS, Stupp IJV, Fraga-Junior EB, Mendonça CB, Rossi FL, Ynoue HN, Doneda DL, Lopes L, Lima E, Buss ZS, Vandresen-Filho S. Neuroprotective effect of melatonin against lipopolysaccharide-induced depressive-like behavior in mice. Physiol Behav 2018;188:270-5. [PMID: 29458118 DOI: 10.1016/j.physbeh.2018.02.034] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
19 Sinha B, Wu Q, Li W, Tu Y, Sirianni AC, Chen Y, Jiang J, Zhang X, Chen W, Zhou S, Reiter RJ, Manning SM, Patel NJ, Aziz-Sultan AM, Inder TE, Friedlander RM, Fu J, Wang X. Protection of melatonin in experimental models of newborn hypoxic-ischemic brain injury through MT1 receptor. J Pineal Res 2018;64. [PMID: 28796402 DOI: 10.1111/jpi.12443] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 12.0] [Reference Citation Analysis]
20 Zhao M, Zhu P, Fujino M, Zhuang J, Guo H, Sheikh I, Zhao L, Li XK. Oxidative Stress in Hypoxic-Ischemic Encephalopathy: Molecular Mechanisms and Therapeutic Strategies. Int J Mol Sci 2016;17:E2078. [PMID: 27973415 DOI: 10.3390/ijms17122078] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 10.8] [Reference Citation Analysis]
21 Pechanova O, Paulis L, Simko F. Peripheral and central effects of melatonin on blood pressure regulation. Int J Mol Sci 2014;15:17920-37. [PMID: 25299692 DOI: 10.3390/ijms151017920] [Cited by in Crossref: 85] [Cited by in F6Publishing: 78] [Article Influence: 12.1] [Reference Citation Analysis]
22 Xu LX, Lv Y, Li YH, Ding X, Wang Y, Han X, Liu MH, Sun B, Feng X. Melatonin alleviates brain and peripheral tissue edema in a neonatal rat model of hypoxic-ischemic brain damage: the involvement of edema related proteins. BMC Pediatr 2017;17:90. [PMID: 28351378 DOI: 10.1186/s12887-017-0824-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
23 Garofoli F, Longo S, Pisoni C, Accorsi P, Angelini M, Aversa S, Caporali C, Cociglio S, De Silvestri A, Fazzi E, Rizzo V, Tzialla C, Zecca M, Orcesi S. Oral melatonin as a new tool for neuroprotection in preterm newborns: study protocol for a randomized controlled trial. Trials 2021;22:82. [PMID: 33482894 DOI: 10.1186/s13063-021-05034-w] [Reference Citation Analysis]
24 McAdams RM, Juul SE. Neonatal Encephalopathy: Update on Therapeutic Hypothermia and Other Novel Therapeutics. Clin Perinatol 2016;43:485-500. [PMID: 27524449 DOI: 10.1016/j.clp.2016.04.007] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 8.6] [Reference Citation Analysis]
25 Romero A, Ramos E, Patiño P, Oset-Gasque MJ, López-Muñoz F, Marco-Contelles J, Ayuso MR, Alcázar A. Melatonin and Nitrones As Potential Therapeutic Agents for Stroke. Front Aging Neurosci 2016;8:281. [PMID: 27932976 DOI: 10.3389/fnagi.2016.00281] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
26 El-Mashad AR, Elmahdy H, El-Dib M, Elbatch M, Aly H. Can melatonin be used as a marker for neonatal sepsis? J Matern Fetal Neonatal Med 2016;29:2870-3. [PMID: 26471842 DOI: 10.3109/14767058.2015.1107898] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
27 Paprocka J, Kijonka M, Rzepka B, Sokół M. Melatonin in Hypoxic-Ischemic Brain Injury in Term and Preterm Babies. Int J Endocrinol 2019;2019:9626715. [PMID: 30915118 DOI: 10.1155/2019/9626715] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
28 Herrera EA, Macchiavello R, Montt C, Ebensperger G, Díaz M, Ramírez S, Parer JT, Serón-ferré M, Reyes RV, Llanos AJ. Melatonin improves cerebrovascular function and decreases oxidative stress in chronically hypoxic lambs. J Pineal Res 2014;57:33-42. [DOI: 10.1111/jpi.12141] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
29 Zhu H, Jin Q, Li Y, Ma Q, Wang J, Li D, Zhou H, Chen Y. Melatonin protected cardiac microvascular endothelial cells against oxidative stress injury via suppression of IP3R-[Ca2+]c/VDAC-[Ca2+]m axis by activation of MAPK/ERK signaling pathway. Cell Stress Chaperones 2018;23:101-13. [PMID: 28669047 DOI: 10.1007/s12192-017-0827-4] [Cited by in Crossref: 111] [Cited by in F6Publishing: 112] [Article Influence: 27.8] [Reference Citation Analysis]
30 Rodrigues Helmo F, Etchebehere RM, Bernardes N, Meirelles MF, Galvão Petrini C, Penna Rocha L, Gonçalves Dos Reis Monteiro ML, Souza de Oliveira Guimarães C, de Paula Antunes Teixeira V, Dos Reis MA, Machado JR, Miranda Corrêa RR. Melatonin treatment in fetal and neonatal diseases. Pathol Res Pract 2018;214:1940-51. [PMID: 30377024 DOI: 10.1016/j.prp.2018.10.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
31 Wu Q, Chen W, Sinha B, Tu Y, Manning S, Thomas N, Zhou S, Jiang H, Ma H, Kroessler DA, Yao J, Li Z, Inder TE, Wang X. Neuroprotective agents for neonatal hypoxic-ischemic brain injury. Drug Discov Today 2015;20:1372-81. [PMID: 26360053 DOI: 10.1016/j.drudis.2015.09.001] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 6.3] [Reference Citation Analysis]
32 Liu S, Guo Y, Yuan Q, Pan Y, Wang L, Liu Q, Wang F, Wang J, Hao A. Melatonin prevents neural tube defects in the offspring of diabetic pregnancy. J Pineal Res 2015;59:508-17. [PMID: 26475080 DOI: 10.1111/jpi.12282] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
33 Ramos E, Patiño P, Reiter RJ, Gil-Martín E, Marco-Contelles J, Parada E, de Los Rios C, Romero A, Egea J. Ischemic brain injury: New insights on the protective role of melatonin. Free Radic Biol Med 2017;104:32-53. [PMID: 28065781 DOI: 10.1016/j.freeradbiomed.2017.01.005] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 13.0] [Reference Citation Analysis]
34 Mohsenpour H, Pesce M, Patruno A, Bahrami A, Pour PM, Farzaei MH. A Review of Plant Extracts and Plant-Derived Natural Compounds in the Prevention/Treatment of Neonatal Hypoxic-Ischemic Brain Injury. Int J Mol Sci 2021;22:E833. [PMID: 33467663 DOI: 10.3390/ijms22020833] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Qin X, Cheng J, Zhong Y, Mahgoub OK, Akter F, Fan Y, Aldughaim M, Xie Q, Qin L, Gu L, Jian Z, Xiong X, Liu R. Mechanism and Treatment Related to Oxidative Stress in Neonatal Hypoxic-Ischemic Encephalopathy. Front Mol Neurosci. 2019;12:88. [PMID: 31031592 DOI: 10.3389/fnmol.2019.00088] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
36 Tarocco A, Caroccia N, Morciano G, Wieckowski MR, Ancora G, Garani G, Pinton P. Melatonin as a master regulator of cell death and inflammation: molecular mechanisms and clinical implications for newborn care. Cell Death Dis 2019;10:317. [PMID: 30962427 DOI: 10.1038/s41419-019-1556-7] [Cited by in Crossref: 69] [Cited by in F6Publishing: 56] [Article Influence: 34.5] [Reference Citation Analysis]
37 Kuthati Y, Lin SH, Chen IJ, Wong CS. Melatonin and their analogs as a potential use in the management of Neuropathic pain. J Formos Med Assoc 2019;118:1177-86. [PMID: 30316678 DOI: 10.1016/j.jfma.2018.09.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
38 Parikh P, Juul SE. Neuroprotection Strategies in Preterm Encephalopathy. Semin Pediatr Neurol 2019;32:100772. [PMID: 31813513 DOI: 10.1016/j.spen.2019.08.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
39 Dixon BJ, Reis C, Ho WM, Tang J, Zhang JH. Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy. Int J Mol Sci 2015;16:22368-401. [PMID: 26389893 DOI: 10.3390/ijms160922368] [Cited by in Crossref: 85] [Cited by in F6Publishing: 79] [Article Influence: 14.2] [Reference Citation Analysis]
40 Shao M, Shen Y, Sun H, Meng D, Huo W, Qi X. Protectiveness of Artesunate Given Prior Ischemic Cerebral Infarction Is Mediated by Increased Autophagy. Front Neurol 2018;9:634. [PMID: 30174640 DOI: 10.3389/fneur.2018.00634] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
41 Shea KL, Palanisamy A. What can you do to protect the newborn brain? Curr Opin Anaesthesiol 2015;28:261-6. [PMID: 25827279 DOI: 10.1097/ACO.0000000000000184] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
42 Bruni O, Alonso-Alconada D, Besag F, Biran V, Braam W, Cortese S, Moavero R, Parisi P, Smits M, Van der Heijden K, Curatolo P. Current role of melatonin in pediatric neurology: clinical recommendations. Eur J Paediatr Neurol 2015;19:122-33. [PMID: 25553845 DOI: 10.1016/j.ejpn.2014.12.007] [Cited by in Crossref: 135] [Cited by in F6Publishing: 92] [Article Influence: 19.3] [Reference Citation Analysis]
43 Reyes-Corral M, Sola-Idígora N, de la Puerta R, Montaner J, Ybot-González P. Nutraceuticals in the Prevention of Neonatal Hypoxia-Ischemia: A Comprehensive Review of their Neuroprotective Properties, Mechanisms of Action and Future Directions. Int J Mol Sci 2021;22:2524. [PMID: 33802413 DOI: 10.3390/ijms22052524] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Yıldız EP, Ekici B, Tatlı B. Neonatal hypoxic ischemic encephalopathy: an update on disease pathogenesis and treatment. Expert Rev Neurother 2017;17:449-59. [PMID: 27830959 DOI: 10.1080/14737175.2017.1259567] [Cited by in Crossref: 64] [Cited by in F6Publishing: 60] [Article Influence: 12.8] [Reference Citation Analysis]
45 Checa-ros A, Muñoz-hoyos A, Molina-carballo A, Muñoz-gallego A, Narbona-galdó S, Jerez-calero A, Augustín-morales MDC. Analysis of Different Melatonin Secretion Patterns in Children With Sleep Disorders: Melatonin Secretion Patterns in Children. J Child Neurol 2017;32:1000-8. [DOI: 10.1177/0883073817726680] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
46 Tan HY, Ng KY, Koh RY, Chye SM. Pharmacological Effects of Melatonin as Neuroprotectant in Rodent Model: A Review on the Current Biological Evidence. Cell Mol Neurobiol 2020;40:25-51. [PMID: 31435851 DOI: 10.1007/s10571-019-00724-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
47 Zhang X, Peng K, Zhang X. The Function of the NMDA Receptor in Hypoxic-Ischemic Encephalopathy. Front Neurosci 2020;14:567665. [DOI: 10.3389/fnins.2020.567665] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
48 Parikh P, Juul SE. Neuroprotective Strategies in Neonatal Brain Injury. J Pediatr 2018;192:22-32. [PMID: 29031859 DOI: 10.1016/j.jpeds.2017.08.031] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
49 Jerez-Calero A, Salvatierra-Cuenca MT, Benitez-Feliponi Á, Fernández-Marín CE, Narbona-López E, Uberos-Fernández J, Muñoz-Hoyos A. Hypothermia Plus Melatonin in Asphyctic Newborns: A Randomized-Controlled Pilot Study. Pediatr Crit Care Med 2020;21:647-55. [PMID: 32168305 DOI: 10.1097/PCC.0000000000002346] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
50 Ahmed MA, Ahmed HI, El-Morsy EM. Melatonin protects against diazinon-induced neurobehavioral changes in rats. Neurochem Res 2013;38:2227-36. [PMID: 23979727 DOI: 10.1007/s11064-013-1134-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
51 Liu F, Wang Y, Yao W, Xue Y, Zhou J, Liu Z. Geniposide attenuates neonatal mouse brain injury after hypoxic-ischemia involving the activation of PI3K/Akt signaling pathway. J Chem Neuroanat 2019;102:101687. [PMID: 31562918 DOI: 10.1016/j.jchemneu.2019.101687] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
52 Tsang JKW, Liu J, Lo ACY. Vascular and Neuronal Protection in the Developing Retina: Potential Therapeutic Targets for Retinopathy of Prematurity. Int J Mol Sci 2019;20:E4321. [PMID: 31484463 DOI: 10.3390/ijms20174321] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
53 Rodriguez J, Li T, Xu Y, Sun Y, Zhu C. Role of apoptosis-inducing factor in perinatal hypoxic-ischemic brain injury. Neural Regen Res 2021;16:205-13. [PMID: 32859765 DOI: 10.4103/1673-5374.290875] [Reference Citation Analysis]
54 Shimomura ET, Briones AJ, Gordon CJ, Warren WS, Jackson GF. Case report of sudden death in a twin infant given melatonin supplementation: A challenging interpretation of postmortem toxicology. Forensic Sci Int 2019;304:109962. [PMID: 31610334 DOI: 10.1016/j.forsciint.2019.109962] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
55 Metwally MMM, Ebraheim LLM, Galal AAA. Potential therapeutic role of melatonin on STZ-induced diabetic central neuropathy: A biochemical, histopathological, immunohistochemical and ultrastructural study. Acta Histochem 2018;120:828-36. [PMID: 30268437 DOI: 10.1016/j.acthis.2018.09.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]